Bronchitis

The prescribing of unnecessary antibiotics in U.S. physician offices and EDs decreased slightly, from 30% to 28%, between 2010 and 2015, according to findings published in Clinical Infectious Diseases.

Patients with nonobstructive chronic bronchitis appear to have a higher risk for adverse respiratory health outcomes, according to a study published in JAMA Internal Medicine.

The FDA black box warning on fluoroquinolones that was issued in 2016 resulted in a significant, further decline in use at 29 southeastern U.S. hospitals, according to a recent study published in Infection Control and Hospital Epidemiology.

N-acetylcysteine significantly reduced exacerbation events among individuals with chronic bronchitis and COPD, according to results of a meta-analysis.